Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma

This study has been completed.
Genentech, Inc.
Information provided by:
Novartis Identifier:
First received: June 4, 2007
Last updated: October 24, 2011
Last verified: October 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)